Thai Drug Facility Licensing and Good Manufacturing and Distribution Practice
Thailand licenses drug facilities by activity rather than by product, and attaches a different good-practice standard to each licence: a manufacturer owes GMDP, an importer owes GDP, and a seller owes GPP. An overseas manufacturing site supplying Thailand does not hold a Thai licence at all — it obtains GMP Clearance from the Thai FDA instead. Thailand has been the 49th PIC/S Participating Authority since 1 August 2016, so its manufacturing expectations track the PIC/S GMP Guide.
Always verify against the current published text before relying on it for a submission or inspection.
Scope & applicability
Drug facilities operating in or supplying Thailand: domestic manufacturing facilities, import facilities, retail and wholesale sales establishments, and overseas manufacturing sites seeking GMP Clearance. Applications are filed with the Thai FDA for facilities in Bangkok and with the Provincial Public Health Office elsewhere.
Quick reference · Which practice standard applies to which Thai licence
Thailand attaches the good-practice obligation to the licence type, not to the product. A site that manufactures and imports holds two licences and owes both duties.
| Licence held | Standard the licensee must comply with |
|---|---|
| Manufacturing facility (domestic) | Good Manufacturing and Distribution Practice (GMDP) |
| Import facility | Good Distribution Practice (GDP) |
| Sales establishment (retail or wholesale) | Good Pharmacy Practice (GPP) |
| Overseas manufacturing facility | GMP Clearance from the Thai FDA |
Licences of every type are renewed yearly, and a pharmacist must be present and on duty at the establishment. Applications go to the Thai FDA in Bangkok, or to the Provincial Public Health Office elsewhere.
Source: Thai FDA, Drug Facility Licensing (en.fda.moph.go.th), 24 May 2023. Verify against the current text before relying on it for a submission.
Key requirements
- Hold the correct licence for each activity — manufacture, import and sale are licensed separately
- Comply with the standard attached to the licence: GMDP for manufacturers, GDP for importers, GPP for sellers
- Obtain GMP Clearance from the Thai FDA for an overseas manufacturing site supplying the Thai market
- Ensure a pharmacist is present and on duty at the sales establishment, manufacturing facility or import facility
- Renew every licence annually; fee rates differ by licence type and standard
Implementation tips
- Map your activities to licences before your products: a site that manufactures and also imports owes both GMDP and GDP
- Treat PIC/S alignment as the working assumption for inspection expectations — Thailand acceded in 2016 and inspects against the PIC/S GMP Guide
- For an overseas site, plan GMP Clearance as a separate, Thailand-specific submission rather than assuming an existing PIC/S-country certificate suffices
- File in the right place: Bangkok applications go to the Thai FDA, provincial ones to the Provincial Public Health Office
Revision notes
Thailand became the 49th PIC/S Participating Authority on 1 August 2016, having applied on 20 March 2015 — the accession that aligned Thai manufacturing expectations with the PIC/S GMP Guide and made Thai certificates legible to other PIC/S authorities. Thailand is a PIC/S member alongside Singapore, Malaysia, Indonesia and Chinese Taipei, and hosts the regional inspection convergence that membership implies.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
Thai FDA GMDP / GMP Clearance: frequently asked questions
Quick answers to common questions about Thai FDA GMDP / GMP Clearance.
What is Thai FDA GMDP / GMP Clearance?
Thai FDA GMDP / GMP Clearance — Thai Drug Facility Licensing and Good Manufacturing and Distribution Practice — is a regulation issued by the Food and Drug Administration, Thailand (Thailand). Thailand licenses drug facilities by activity rather than by product, and attaches a different good-practice standard to each licence: a manufacturer owes GMDP, an importer owes GDP, and a seller owes GPP. An overseas manufacturing site supplying Thailand does not hold a Thai licence at all — it obtains GMP Clearance from the Thai FDA instead. Thailand has been the 49th PIC/S Participating Authority since 1 August 2016, so its manufacturing expectations track the PIC/S GMP Guide.
Who does Thai FDA GMDP / GMP Clearance apply to?
Drug facilities operating in or supplying Thailand: domestic manufacturing facilities, import facilities, retail and wholesale sales establishments, and overseas manufacturing sites seeking GMP Clearance. Applications are filed with the Thai FDA for facilities in Bangkok and with the Provincial Public Health Office elsewhere.
What are the key requirements of Thai FDA GMDP / GMP Clearance?
Thai FDA GMDP / GMP Clearance requires, among other things: Hold the correct licence for each activity — manufacture, import and sale are licensed separately; Comply with the standard attached to the licence: GMDP for manufacturers, GDP for importers, GPP for sellers; Obtain GMP Clearance from the Thai FDA for an overseas manufacturing site supplying the Thai market; Ensure a pharmacist is present and on duty at the sales establishment, manufacturing facility or import facility.
When was Thai FDA GMDP / GMP Clearance last updated?
The current version of Thai FDA GMDP / GMP Clearance dates from May 2023. Thailand became the 49th PIC/S Participating Authority on 1 August 2016, having applied on 20 March 2015 — the accession that aligned Thai manufacturing expectations with the PIC/S GMP Guide and made Thai certificates legible to other PIC/S authorities. Thailand is a PIC/S member alongside Singapore, Malaysia, Indonesia and Chinese Taipei, and hosts the regional inspection convergence that membership implies.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.